Ticker / mid cap

DNTH

Dianthus Therapeutics, Inc.
0
Contracts
$0
Total Value

Stock Metrics

15.3%
Short % Float
9.5d to cover · Moderate squeeze
1.4%
Inst % Float
10 holders · 2026-06-30
FMR, LLC
Top Holder
13.9% of float
54.6M sh
Public Float
41/100
Dilution Score
Medium
125 mo
Cash Runway
Verified regulatory filings & proprietary analysis.

Fleet Intelligence

Dilution Risk
41/100
MEDIUM
Inst: 1.36% · Top: FMR, LLC
Biotech Analytics
D
Biotech / Pharma
46.66
Squeeze risk: MODERATEBiotech Grade: D

Biotech Analytics D Biotech / Pharma · score 46.66

Insider Buying0
Publications100
Dilution Risk41
Clinical Trials75
Short Interest50